Table 1. Bivariate analysis of patients: MDT participants and non-participants.

Variables		Total		Non-MDT		MDT		P value
		N	%	N	%	N	%
Total		32569	100.00	27937	85.78	4632	14.22
Gender								<0.001
	Female	11536	35.42	9780	84.78	1756	15.22
	Male	21033	64.58	18157	86.33	2876	13.67
Age at diagnosed								<0.001
	Under 44	1758	5.4	1495	85.04	263	14.96
	45–54	4666	14.33	3938	84.4	728	15.6
	55–64	7060	21.68	5964	84.48	1096	15.52
	65–74	9489	29.14	8127	85.65	1362	14.35
	Above 75	9596	29.46	8413	87.67	1183	12.33
Mean age at diagnosed		66.13	12.50	66.29	12.51	65.15	12.40
CCI score								<0.001
	0–3	14533	44.62	12333	84.86	2200	15.14
	4–6	5990	18.39	5152	86.01	838	13.99
	Above 7	12046	36.99	10452	86.77	1594	13.23
Catastrophic illness/injury								0.100
	Without	31523	96.79	27021	85.72	4502	14.28
	With	1046	3.21	916	87.57	130	12.43
Cancer stage								0.079
	Stage I	3520	10.81	2981	84.69	539	15.31
	Stage II	1102	3.38	931	84.48	171	15.52
	Stage III	9378	28.79	8034	85.67	1344	14.33
	Stage IV	18569	57.01	15991	86.12	2578	13.88
Cancer stage								0.018
	Stage I+II	4622	14.19	3912	84.64	710	15.36
	Stage III+IV	27947	85.81	24025	85.97	3922	14.03
Hospital level								<0.001
	Medical center	22293	68.45	20010	89.76	2283	10.24
	Regional hospital	9739	29.9	7424	76.23	2315	23.77
	District hospital	537	1.65	503	93.67	34	6.33
Hospital ownership								<0.001
	Public	12706	39.01	11721	92.25	985	7.75
	Private	19863	60.99	16216	81.64	3647	18.36
Service volume of hospital								<0.001
	Low	1313	4.03	1182	90.02	131	9.98
	High	31256	95.97	26755	85.6	4501	14.4

This study was approved by the institutional review board (IRB) of China Medical University and Hospital (IRB number: CMUH102-REC3-076).